$732M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | CGON Cg Oncology Inc | 6.4M | +0.0% | $453M | 61.9% |
| 2 | NUVB Nuvation Bio Inc | 26.0M | +0.0% | $147M | 20.1% |
| 3 | AARD Aardvark Therapeutics Inc | 3.9M | +0.0% | $23M | 3.1% |
| 4 | ACRS Aclaris Therapeutics Inc | 4.0M | +0.0% | $21M | 2.9% |
| 5 | UPB Upstream Bio Inc | 2.7M | +0.0% | $19M | 2.6% |
| 6 | RCUS Arcus Biosciences Inc | 464,779 | −2.7% | $14M | 2.0% |
| 7 | EQ Equillium Inc | 4.4M | +0.0% | $14M | 1.9% |
| 8 | RVMD Revolution Medicines Inc | 52,667 | −43.7% | $10M | 1.3% |
| 9 | LYEL Lyell Immunopharma, Inc. | 692,050 | +0.0% | $10M | 1.3% |
| 10 | BYSI BeyondSpring Inc. | 3.8M | +0.0% | $7M | 0.9% |
| 11 | ZNTL Zentalis Pharmaceuticals Inc | 1.3M | +0.0% | $6M | 0.9% |
| 12 | NAMS Newamsterdam Pharma Company | 176,887 | −45.6% | $6M | 0.8% |
| 13 | PYXS Pyxis Oncology Inc | 326,810 | +0.0% | $983,698 | 0.1% |
| 14 | TNGX Tango Therapeutics Inc | 20,000 | — | $625,200 | 0.1% |